Add BrightSurf on Google Email

Carol J. Levy, MD, CDCES, named Chief of Endocrinology, Diabetes and Bone Disease at Mount Sinai Health System

Carol J. Levy, MD, CDCES, has been appointed as Chief of the Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai Health System. Dr. Levy brings extensive experience in diabetes care, research, and education, having led the Mount Sinai Diabetes Center and established the outpatient artificial pancreas program.

Jeonbuk National University study reveals why diabetics are more vulnerable to air pollution's cellular toll

A Jeonbuk National University study found that PM2.5 exposure accelerates bone marrow stem cell aging and impairs regenerative function in diabetic mice, worsening liver injury and fat accumulation. Inflammation and oxidative stress play a key role in these effects.

SourceJeonbuk National University, Sustainable Strategy team, Planning and Coordination Division·JournalJournal of Hazardous Materials·TypeExperimental study·DateOct 29, 2026

Endocrinologists who demonstrate greater medical knowledge more likely to prescribe a recommended treatment for patients with type 2 diabetes

A study found that endocrinologists who scored higher on the American Board of Internal Medicine's Longitudinal Knowledge Assessment were more likely to prescribe key diabetes drug classes following a treatment guidelines update. The study analyzed Medicare claims data from 2017 to 2022 and included 1,061 endocrinologists caring for 17...

SourceAmerican Board of Internal Medicine·JournalJAMA Network Open·TypeObservational study·DateOct 27, 2026

Penn engineers use AI, Reddit to identify potential side effects of unapproved new GLP-1

Researchers used AI to analyze nearly 150,000 Reddit posts about unapproved GLP-1 weight loss drug retatrutide, identifying potential side effects that differ from clinical trial results. The study found increased appetite to be the most frequently reported symptom, which contrasts with gastrointestinal complaints identified in Phase 2...

SourceUniversity of Pennsylvania School of Engineering and Applied Science·JournalJAMA Network Open·TypeData/statistical analysis·DateOct 15, 2026

Longer sleep may be linked to a higher risk of kidney disease in people with type 2 diabetes

A study published in the Journal of the Endocrine Society found that people with type 2 diabetes who sleep longer may be at a higher risk of developing or worsening diabetic kidney disease. Longer sleep duration was particularly associated with an increased risk among older adults and those with existing kidney damage.

SourceThe Endocrine Society·JournalJournal of the Endocrine Society·DateOct 8, 2026

Men with low or high testosterone may have higher risk of irregular heartbeat

A review of existing evidence on testosterone and heart health found that both low and high testosterone levels increase the risk of atrial fibrillation. The risk appears to follow a U-shaped pattern, with the lowest risk in the middle of the normal testosterone range. This suggests that treatment should be individualized and monitored.

SourceThe Endocrine Society·JournalJournal of the Endocrine Society·DateSep 1, 2026

Endocrine-disrupting chemical exposure may be linked to high blood pressure during pregnancy

A recent study published in the Journal of the Endocrine Society suggests a link between exposure to phthalates and elevated blood pressure during pregnancy. Pregnant women with higher levels of fragrance-associated phthalates were found to have higher systolic and diastolic blood pressure markers, increasing their risk of hypertensive...

SourceThe Endocrine Society·JournalJournal of the Endocrine Society·DateAug 10, 2026

Hidden hormone–habitat relationship revealed in reef fish

Researchers discovered a strong link between environmental variation and thyroid hormone signaling in reef fish, enabling them to adapt to changing habitats. The study found that habitat impacts development by altering gene expression and metabolic profiles, giving animals more flexibility when their environments change.

SourceOkinawa Institute of Science and Technology (OIST) Graduate University·JournalScience Advances·TypeExperimental study·DateAug 7, 2026

Growth hormone therapy helps childhood stem cell transplant survivors grow taller, but responses vary widely

A Japan-wide study found that growth hormone therapy improves adult height in childhood stem cell transplant survivors with short stature. However, treatment responses were highly variable and influenced by transplant-related factors such as total body irradiation and chronic graft-versus-host disease.

SourceHiroshima University·JournalFrontiers in Endocrinology·TypeData/statistical analysis·DateAug 7, 2026

Type 1 diabetes incidence and prevalence in the US

A cross-sectional study examines state-level type 1 diabetes burden and pediatric endocrinology resource distribution in the US. The study found that type 1 diabetes incidence has increased over time, while pediatric endocrinology resources are not evenly distributed across states.

SourceJAMA Network·JournalJAMA Network Open·DateAug 7, 2026

Lancet definition vs other criteria for obesity diagnosis in adults

The Lancet Diabetes and Endocrinology Commission on Obesity definition of obesity was found to have similar diagnostic accuracy as other definitions. The study compared the commission's definition with those from other reputable sources, including the World Health Organization (WHO) and the National Institutes of Health (NIH).

SourceJAMA Network·JournalJAMA Network Open·DateAug 7, 2026

New position statement calls for systematic bone health optimization before joint replacement and spinal fusion surgery

A new position statement calls for systematic bone health optimization before joint replacement and spinal fusion surgery. Key findings include the progressive mechanical failure of bone-implant constructs resulting from compromised bone quality, particularly due to osteoporosis.

SourceInternational Osteoporosis Foundation·JournalOsteoporosis International·TypeLiterature review·DateJul 20, 2026

Chonnam National University researchers reveal isoform-specific HIF signaling in skeletal muscles

Mouse study uncovers how oxygen-sensing transcription factors regulate muscle physiology, improving glucose tolerance and producing erythropoietin. The findings suggest that selectively targeting each isoform can lead to different physiological outcomes.

SourceChonnam National University, The Research Information Management Team, Office of Research Promotion·JournalJournal of Clinical Investigation·TypeExperimental study·DateJul 13, 2026

Breakthrough treatment for weight dysregulation after brain tumors

A clinical trial has shown that setmelanotide, a new drug, can achieve significant weight loss in people whose weight has become dysregulated following treatment for a brain tumor. The treatment resulted in a 20% reduction in BMI, with participants experiencing substantial health benefits.

SourcePrincess Máxima Center for Pediatric Oncology·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateJul 8, 2026

Not all children with early puberty need the same level of testing or treatment

Children who start puberty earlier than usual may not need the same level of testing or treatment, according to a new Endocrine Society Clinical Practice Guideline. The guideline suggests different approaches for various subgroups, including monitoring girls with slow progression and using simpler testing methods.

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology & Metabolism·DateJun 13, 2026

Mount Sinai opens Carolyn Rowan Center for Women’s Health and Wellness, a new model of coordinated care across the lifespan

The Mount Sinai Health System has opened the Carolyn Rowan Center for Women’s Health and Wellness, which brings together multidisciplinary clinical expertise, structured care pathways, and leading-edge research to deliver personalized, comprehensive care for women. The Center offers guided multi-visit experiences and coordinated care o...

Targeted therapy improves mobility in children with rare bone disorder

A phase 2 clinical trial found that burosumab safely restored normal phosphate levels and improved physical function in patients with severe fibrous dysplasia. Key findings include reduced pain, fatigue, and mobility impairment, as well as significant improvements in children's mobility and independence.

SourceEditorial Office of West China School of Stomatology, Sichuan University·JournalBone Research·TypeRandomized controlled/clinical trial·DateMay 20, 2026